secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONTRAFECT Corp (—)
CIK:        0001478069
Form:       8-K
Filed at:   2022-11-25T23:59:59+00:00
Accession:  0001193125-22-292616
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ContraFect gets Nasdaq deficiency letter; equity -$3.1M vs $2.5M minimum; bid price still deficient
--------------------------------------------------------------------------------

- Stockholders' equity as of Sept 30, 2022 was $(3.1M), below Nasdaq's $2.5M continued listing requirement.
- Company has 45 days (until Jan 6, 2023) to submit a plan to regain compliance with Nasdaq Rule 5550(b)(1).
- Prior bid price deficiency from Aug 25, 2022 (below $1.00 for 30 days) remains uncured.
- If plan is accepted, Nasdaq may grant up to 180 days (to May 21, 2023) to show compliance.
- No immediate effect on trading; company evaluating options but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/0001193125-22-292616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/d421710d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-292616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer